Why is Soni Medicare falling/rising?

As of 31-Jul, Soni Medicare Ltd is currently priced at 58.00, with no change in price (0.00%). The stock has shown a positive performance over the past week, increasing by 0.43%, and has significantly outperformed the Sensex, which has declined by 1.22% during the same period. However, today the stock underperformed its sector by 0.72%, and there has been a notable decrease in investor participation, with delivery volume falling by 87.12% against the 5-day average. Despite these short-term challenges, the stock has demonstrated strong long-term performance, with a year-to-date return of 77.70% and a remarkable 98.43% return over the past year, supported by a rise in profits of 89.3%. The company's attractive valuation, trading at a discount compared to peers, also contributes positively to its stock movement.
In the broader market context, while Soni Medicare has outperformed the BSE500, which has generated negative returns of -3.20% over the past year, the stock's recent performance is tempered by its high debt levels, indicated by a Debt-Equity Ratio of 6.6 times and a Debt to EBITDA ratio of 4.34 times, which raises concerns about its long-term fundamental strength. The flat results reported in March and the low Debtors Turnover Ratio further highlight potential weaknesses. Overall, while the stock has shown impressive returns relative to the market, the combination of high debt and declining investor participation may be contributing to a cautious outlook among investors.